Delirium Related to Datura Seeds in a Patient with Major Depressive Disorder with a Suicide Attempt
Journal of Medical Sciences · 2026-07 · 46 (4) · 209-210
DOI: 10.4103/jmedsci.jmedsci_77_26 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Sciences, online erschienen am 03.07.2026. Verfasst von Yu-Ming Wu und 3 weiteren Autor:innen. Die Arbeit nennt 5 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Delir
Abstract (Originalsprache)
Dear Editor, Seeds and leaves of Datura stramonium (D. stramonium) are rich in tropane alkaloids, including scopolamine, hyoscyamine, and atropine.1Datura poisoning manifests with anticholinergic symptoms. Here, we present a rare case of delirium related to the ingestion of Datura seeds following a suicide attempt by a 17-year-old male. A 17-year-old male, diagnosed with major depressive disorder at the age of 16 years, had been treated with fluoxetine, lithium, and aripiprazole. In addition, he was receiving repetitive transcranial magnetic stimulation. He purchased Datura seeds online and consumed 40 seeds in a suicide attempt. Subsequently, he developed symptoms including dry mouth, dizziness, and palpitations. He was brought to the emergency department, where he received pyridostigmine 60 mg orally. He voluntarily left the emergency department after treatment. Two weeks later, the patient ingested approximately 360 Datura seeds in another suicide attempt. In the emergency department, gastric lavage via a nasogastric tube with activated charcoal was performed. The patient presented with tachycardia (114 bpm), hypertension (148/85 mm Hg), and a body temperature of 37.2°C. Physical examination revealed bilateral mydriasis (6 mm) with absent light reflexes. He experienced an anticholinergic toxidrome, characterized by delirium, including disorientation, confusion, and disorganized speech. The patient was admitted to the intensive care unit. Blood test results remained within normal limits. A central venous line and an arterial line were placed as a precaution against potential hemodynamic instability. A national poison control center was consulted, and while neostigmine was discussed as a treatment option, the attending physician chose to maintain supportive management without pharmacological intervention. After 24 h of observation, his symptoms completely resolved, likely due to the short half-life (2–4 h) of anticholinergic compounds. Once his vital signs were stable, he was transferred to a general medical ward. Following a total hospital stay of 4 days, the patient was discharged with arrangements for ongoing psychiatric follow-up. Most cases of Datura poisoning resolve with supportive treatment, but may still be fatal.2 Symptoms usually appear within 60 min post-ingestion and include vivid hallucinations, dry mucous membranes, dilated pupils, and delirium.3 A prominent hypothesized cause of delirium is central cholinergic deficiency. This blockade disrupts normal cholinergic neurotransmission, which is essential for cognitive processes and consciousness. The resulting deficiency impairs cortical activation and network connectivity, leading to the acute onset of confusion, inattention, and fluctuating mental status characteristic of delirium.4 Physostigmine is the antidote of choice for severe Datura poisoning presenting with at least one of the following features: Arrhythmias, hallucinations, severe hypertension, convulsions, or coma. Neostigmine and pyridostigmine do not cross the blood–brain barrier and therefore are not effective in countering atropine-induced central nervous system toxicity.5 Attempted suicide cases of Datura poisoning reported in the literature remain rare.2 In Taiwan, Datura seeds can be purchased online for gardening purposes, with limited oversight from relevant government agencies. This report aims to raise awareness among healthcare providers of the potential risks associated with toxic plants in the environment and underscores the importance of selecting physostigmine as the definitive antidote for managing central anticholinergic toxicity. Acknowledgments We would like to thank Tim Huang of the Community Services Center Taipei for English language proofreading. Declaration of patient consent This study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and was approved by the Institutional Review Board of Tri-Service General Hospital (IRB# B202515159). The authors certify that they have obtained appropriate consent forms from the legal guardians of the patient. In the form, the guardians have given the consent for the images and other clinical information of the patient to be reported in the journal. The guardians understand that the name and initials of the patient will not be published and due efforts will be made to conceal the identity, but anonymity cannot be guaranteed. Data availability statement Data sharing does not apply to this article as no datasets were generated or analyzed during the current study. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.
Zitieren
APA
Wu, Y., Chen, J., Chen, W., & Tzeng, N. (2026). Delirium Related to Datura Seeds in a Patient with Major Depressive Disorder with a Suicide Attempt. Journal of Medical Sciences, 46(4), 209-210. https://doi.org/10.4103/jmedsci.jmedsci_77_26
Vancouver
Wu Y, Chen J, Chen W, Tzeng N. Delirium Related to Datura Seeds in a Patient with Major Depressive Disorder with a Suicide Attempt. Journal of Medical Sciences. 2026;46(4):209-210. doi:10.4103/jmedsci.jmedsci_77_26
BibTeX
@article{Wu2026,
author = {Wu, Yu-Ming and Chen, Jung-Chieh and Chen, Wan-Ting and Tzeng, Nian-Sheng},
title = {Delirium Related to Datura Seeds in a Patient with Major Depressive Disorder with a Suicide Attempt},
journal = {Journal of Medical Sciences},
year = {2026},
volume = {46},
number = {4},
pages = {209--210},
doi = {10.4103/jmedsci.jmedsci_77_26}
}
EUVIMED